|Bid||1.8600 x 0|
|Ask||1.8800 x 0|
|Day's Range||1.8400 - 1.8800|
|52 Week Range||1.8400 - 1.8800|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER , March 14, 2019 /CNW/ - Trading resumes in: Company: Emblem Corp. TSX-Venture Symbol: EMC (all issues) Resumption (ET): 12:45 PM IIROC can make a decision to impose a temporary suspension (halt) ...
VANCOUVER , March 14, 2019 /CNW/ - The following issues have been halted by IIROC: Company: Emblem Corp. TSX-Venture Symbol: EMC (all issues) Reason: At the Request of the Company Pending News Halt Time ...
NEW YORK, March 12, 2019 /CNW/ -- Over the past few years, the number of companies entering into the cannabis industry has consistently risen. Canada's recent legalization of cannabis and the rapid spread of public support ongoing in the U.S. has led to the emergence of new cannabis players within the marketplace. The overall cannabis market is expected to accelerate as global legalization continues to spread for both recreational and medical applications.
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) is pleased to announce that it has received a final order from the Ontario Superior Court of Justice (Commercial List) approving the previously announced plan of arrangement (the “Arrangement”) with Aleafia Health Inc. (“Aleafia”) described in the joint press release issued by Emblem and Aleafia on December 19, 2018. Assuming the satisfaction or waiver of these remaining closing conditions, it is anticipated that the Arrangement will be completed on or around March 14, 2019.
Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) announced today that the Company has received conditional approval from the Toronto Stock Exchange (“TSX”) to graduate from the Toronto Venture Exchange (“TSXV”) and list its common shares on the TSX under the symbol “ALEF”. Listing on the TSX is subject to TSX final approval which is conditional upon the completion of the Company’s previously announced acquisition of Emblem Corp. (TSXV: EMC, OTCQX: EMMBF). In conjunction with listing on the TSX, the common shares will be voluntarily delisted from the TSXV prior to the commencement of trading on the TSX.
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) is pleased to announce that, at the special meeting of shareholders of Emblem held today (the “Meeting”), the shareholders of Emblem voted in favour of a special resolution to approve the proposed arrangement (the “Arrangement”) involving Emblem and Aleafia Health described in the joint press release issued by Emblem and Aleafia on December 19, 2018, as well as certain other Meeting matters. The Arrangement required approval by 66 ⅔% of the votes cast by shareholders present in person or represented by proxy at the Meeting.
Now, cannabis is rapidly emerging around the globe as countries begin to reverse the laws and legalize its medicinal use again. While most countries are exploring opportunities within the medical cannabis sector, the proliferation of recreational cannabis is rapidly spreading throughout the western hemisphere of the world. Currently, the U.S. and Canada dominate the recreational sector, however, countries in Latin America are also looking to legalize cannabis for adult-use.
RBC Capital Markets analyst Nik Modi said that U.S. cannabis sales are rapidly growing, as he projects that sales could top USD 47 Billion within the next decade, according to Business Insider. Nielsen Holdings, a U.S.-based data firm, also says that sales of alcohol are slowing down, however, the expansion of places that serve alcoholic beverages have expanded. The ISWR and BDS Analytics recently said in a report that trends suggest that millennials are choosing cannabis-based products over alcoholic beverages nowadays as well.
White to Lead Integration of Canabo Medical Clinics and GrowWise Health Post-closing of Emblem AcquisitionPreviously the COO of Canada’s Largest Multidisciplinary Clinic Network.
NEW YORK, Feb. 11, 2019 /CNW/ -- The misconceptions propagated about the cannabis plant had led to decades of prohibition, but recent research and studies have shed light on the truth. Studies have shown that parts of the cannabis plant are actually non-psychoactive and that the plant can be broken down into two other derivatives: hemp and marijuana. With the growing adoption and acceptance of hemp, there are expectations that the overall cannabis industry will expand even further.
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) announces that the Ontario Superior Court of Justice (Commercial List) granted the Company’s motion for an interim order authorizing various matters, including the mailing of a management information circular (the “Circular”) and the holding of the special meeting of Emblem shareholders to be held on Wednesday March 6, 2019 at 10:30 a.m. (Toronto time) at the offices of Dentons Canada LLP, 77 King Street West, Suite 400, Toronto, Ontario, M5K 0A1 (the “Meeting”). The Meeting will be held to consider the previously announced proposed arrangement (the “Arrangement”) involving Emblem and Aleafia Health Inc. (“Aleafia”) described in the joint press release issued by Emblem and Aleafia on December 19, 2018 (the “Arrangement”), as well as certain other Meeting matters as set out in the Circular mailed to shareholders.
With so many legal initiatives occurring throughout the industry in North America and beyond, the cannabis industry has garnered copious amounts of public approval, resulting in the increase in investor excitement emanating from those looking for promising opportunities. Some studies have shown that the global cannabis industry is worth as much as $50 billion, which, if conditions remain the same, will only grow over time. GTEC Holdings Ltd (TSXV:GTEC) (OTCQB:GGTTF), Emblem Corp (EMMBF) (EMC.V), Charlotte's Web Holdings Inc (CWBHF), and Cronos Group Inc (CRON) represent four companies committed to integrating cannabis as a means of improving the quality of life for consumers on a global scale.
Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“Aleafia Health”) or the (“Company”) is announcing its global expansion with the closing of its previously announced investment in CannaPacific Pty Limited (“CannaPacific”), a federally licensed Australian medical cannabis company located in New South Wales, Australia. CannaPacific is licensed by the Office of Drug Control (ODC) of Australia to cultivate medical cannabis (License MC020/18) and to research medical cannabis (License RL 012/18).
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) through its wholly-owned subsidiary Emblem Cannabis Corporation, today announced that Emblem-branded cannabis oils are now available online through Shoppers Drug Mart to patients with a valid medical authorization. Emblem’s state-of-the-art indoor cannabis cultivation facility and Product Innovation Centre is located in Paris, Ontario.
Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia” or the “Company”) has completed Phase I construction and retrofitting of its Niagara Greenhouse facility (“Niagara”) located in Grimsby, Ontario. The Company expects to complete Phase II of the construction and retrofitting on the balance of the facility in late Q1 or early Q2 2019. The Company has also submitted the facility’s Evidence Package to Health Canada, marking the final stage in the Cultivation Licence application process.
Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres;Aleafia patients to access Emblem’s.
NEW YORK, NY / ACCESSWIRE / December 18, 2018 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us ...
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, today announced the launch of a new line of 10mg Emblem Oil Capsules, providing its growing list of 6,000+ patients with a pre-dosed treatment format. The 10mg Emblem Oil Capsules offer a consistent patient experience formulated with three chemovar specific formats - High THC (10mg THC per capsule), High CBD (10 mg CBD per capsule) and Balanced (6mg THC/10 mg CBD per capsule).
Revenues increase 281% over the quarter ended September 30, 2017 and 50% over Q2 2018 TORONTO, Nov. 20, 2018 -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the.
NEW YORK, NY / ACCESSWIRE / November 16, 2018 / MarketEdge Report strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with ...